Page 47 - Device Designation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Innovative multidisciplinary research at Washington University led to development of 'breakthrough' device Eric Leuthardt, MD, professor of neurosurgery at Washington University School of Medicine, models a device that helps people disabled by stroke regain significant control over their arm and hand function by using their minds. Called the IpsiHand Upper Extremity Rehabilitation System, the first-of-its-kind device has received market authorization from the Food and Drug Administration. It was developed by Neurolutions Inc., a Washington University startup company that leverages brain-compu...

Neurolutions Receives U.S. Food and Drug Administration De Novo Market Authorization for IpsiHand™ Upper Extremity Rehabilitation System April 26, 2021 07:00 ET | Source: Neurolutions Neurolutions IpsiHand also has been granted U.S. FDA Breakthrough Device Designation SANTA CRUZ, Calif. and ST. LOUIS, Mo., April 26, 2021 (GLOBE NEWSWIRE) -- Neurolutions, Inc., a medical device company developing and commercializing a first-of-its-kind device leveraging brain-computer interface (BCI) technology for upper extremity chronic stroke rehabilitation, announced today th...

BrainQ hopes to uses AI-based electromagnetic therapy to reduce disability following a stroke (Courtesy) Israeli startup BrainQ said that a pilot trial of 25 stroke patients treated with its artificial intelligence (AI)-based electromagnetic therapy has shown “striking” results in reducing disability following a stroke. The Jerusalem-based startup has developed a wearable hat-like device that looks like a large round hair-dryer. This cloud-connected device aims to treat damaged areas of the brain with electromagnetic waves, or “artificial brainwaves,” that mimic healthy neural network...

Cerus Endovascular Receives FDA Breakthrough Device Designation for its Contour Neurovascular System™ News provided by Share this article Share this article FREMONT, Calif. and OXFORD, United Kingdom, Feb. 11, 2021 /PRNewswire/ -- Cerus Endovascular Ltd., a privately-held, commercial-stage medical device company, today announced that it has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its Contour Neurovascular System™. Breakthrough Device Designation is granted to medical devices and device-led combination products that provide the potentia...